File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy

TitleIn hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy
Authors
Marcellin, PChan, HLYLai, CLClio, MHeathcote, IMoon, YMChao, YCMyers, RHarb, GBrown, NA
Issue Date2007
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
Journal of Hepatology, v. 46 n. Suppl 1, p. S193 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/101063
ISSN
0168-8278
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112

 

DC FieldValueLanguage
dc.contributor.authorMarcellin, Pen_HK
dc.contributor.authorChan, HLYen_HK
dc.contributor.authorLai, CLen_HK
dc.contributor.authorClio, Men_HK
dc.contributor.authorHeathcote, Ien_HK
dc.contributor.authorMoon, YMen_HK
dc.contributor.authorChao, YCen_HK
dc.contributor.authorMyers, Ren_HK
dc.contributor.authorHarb, Gen_HK
dc.contributor.authorBrown, NAen_HK
dc.date.accessioned2010-09-25T19:34:30Z-
dc.date.available2010-09-25T19:34:30Z-
dc.date.issued2007en_HK
dc.identifier.citationJournal of Hepatology, v. 46 n. Suppl 1, p. S193en_HK
dc.identifier.issn0168-8278en_HK
dc.identifier.urihttp://hdl.handle.net/10722/101063-
dc.languageengen_HK
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhepen_HK
dc.relation.ispartofJournal of Hepatologyen_HK
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.en_HK
dc.titleIn hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacyen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0168-8278&volume=46&issue=Suppl 1&spage=S193&epage=&date=2007&atitle=In+hepatitis+B+patients+treated+with+either+adefovir+or+telbivudine,+maximal+early+hbv+suppression+at+24+weeks+predicts+optimal+one-year+efficacyen_HK
dc.identifier.emailLai, CL: hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.identifier.hkuros152472en_HK
dc.identifier.volume, v. 46 n. Suppl 1en_HK
dc.identifier.issueSuppl 1en_HK
dc.identifier.spage193en_HK
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats